People with Parkinson's disease who have less social interaction are at greater risk for developing more severe symptoms of the disease than those who are less lonely. Read More
A chemical assay can detect traces of Parkinson's related alpha-synuclein from skin samples. Read More
Parkinson's patients have reduced acylated-ghrelin to unacylated-ghrelin ratios in their blood. Lower levels of unacylated-ghrelin have been associated with a reduced ability to generate new neurons and memory impairments. Read More
Parkinson's patients carrying mutations in PINK1 and Parkin genes have increased levels of circulating interleukin 6 and mitochondrial DNA. The findings strengthen a link between genetic risk factors from Parkinson's disease and inflammation. Read More
An examination of brainstems from children and young adults constantly exposed to air pollution reveals markers of Alzheimer's disease, Parkinson's disease, and motor neuron disease. Findings suggest air pollution poses risks of serious neurological damage from an early age. Read More
People with Parkinson's disease have a 30% higher risk of dying from coronavirus infection than those without the neurodegenerative disorder. A new study suggests Parkinson's is an independent risk factor for COVID-19 mortality. Read More
For carriers of the Parkinson's related LRRK2 gene, coffee consumption can help lower the risk of developing symptoms of the disease. Read More
Spinal cord stimulation significantly decreased pain and reduced motor symptoms associated with Parkinson's disease, both as a singular therapy and for those who deep brain stimulation proved ineffective. Read More
Stem cells derived neurons integrate well into the correct regions of the brain, connecting with native neurons and restoring motor function in mouse models of Parkinson's disease. Read More
Parkinson's disease can be divided into two variants that start in different places in the body. For some, the neurodegenerative disease starts in the intestines and spreads to the brain. In others, the disease begins in the brain and spreads to the intestines and other organs. Read More
Study suggests an alternative strategy for restoring cellular abnormalities in in-vitro models of Parkinson's disease. Read More
Anticholinergic medications, commonly used for conditions including allergies, high blood pressure, Parkinson's disease, and motion sickness, have been linked to an increased risk of cognitive decline and memory problems, especially in those with genetic risk factors for Alzheimer's disease. Read More
